Found: 6
Select item for more details and to access through your institution.
Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04550-0
- By:
- Publication type:
- Article
Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1008301
- By:
- Publication type:
- Article
Neonatal oral myiasis caused by the larvae of Sarcophaga ruficornis (Diptera: Sarcophagidae): a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
- Published in:
- 2022
- By:
- Publication type:
- journal article
KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.
- Published in:
- Theranostics, 2022, v. 12, n. 4, p. 1500, doi. 10.7150/thno.66142
- By:
- Publication type:
- Article
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 9, p. 1592, doi. 10.7150/jca.83853
- By:
- Publication type:
- Article